Bestzyme, established in 2013, is a subsidiary of Genscript Biotech Corporation, a publicly listed company on the Hong Kong Stock Exchange. It specializes in enzyme preparations and synthetic biology products. Over the past 11 years, Bestzyme has upheld its innovative philosophy of “independent research, breaking through core product technologies, and fully owning intellectual property rights.” The company has successfully developed and commercialized numerous proprietary enzyme preparations and biopharmaceutical raw molecules, serving applications in food processing, animal feed, personal care, and other industries. It has grown into an influential and innovative player in its field.

As the company enters a new phase of development, June 2024 marks the launch of Bestzyme’s new brand logo and corporate visual identity system (VI system). This upgrade supports Bestzyme’s global strategic expansion and exploration into new business domains, aligning more closely with its mission of “making people and nature healthier through biotechnology.”

The upgraded logo builds upon Bestzyme’s original brand elements: a leaf symbolizing nature, and hands representing collaboration and mutual support. These elements have been redesigned to enhance precision and stability. The new custom-designed English and Chinese fonts integrate details from the logo, featuring rounded corners and cut-line designs that enhance approachability and readability.